About pharmacological treatment in 2 groups, there was a statistical significant difference about lowering lipid drugs, insulin therapy, oral anti diabetic medications, and antihypertensive drugs [32 (71%) vs 23 (52%), P = 0.042; 15 (32%) vs 4 (9%), P = 0.041; 26 (58%) vs 13 (29%), P = 0.022; 18 (40%) vs 8 (17%), P = 0.043; 23 (51%) vs 15 (32%), P = 0.033; 34 (74%) vs 17 (38%), P = 0.034], comparing MS versus no MS patients, respectively (Table 1). This evidence concerns the gene INS and myeloid sarcoma.